InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: hschlauch post# 42835

Friday, 01/19/2018 9:13:42 PM

Friday, January 19, 2018 9:13:42 PM

Post# of 48316
hschlauch, I have a question for you because you are the "science Man". InhibRX is a TAP collaborator with Oncosec and I noticed that they are licensing a mAb from Celgene in their clinical studies. Do you see the possibility of Celgene being a partner for Oncosec's multi-gene construct (PIIM)? This has been very hush hush and all other collaborators on Oncosec's website have been removed, but these collaborations obviously are ongoing since they were just recently mentioned in the 2018 outlook pr.

below is the link to inhibRX....appreciate any incites you might have about the possibility of a Celgene partnership. Most are just thinking Merck or Bristol Myers for anti-pd1.

http://inhibrx.com/therapeutic-areas/oncology/